Hypera SA ADR HYPMY
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $5.05
- Day Range
- $4.96–5.36
- 52-Week Range
- $3.72–5.77
- Bid/Ask
- $3.39 / $5.36
- Shares Outstanding
- 704.00M
- Market Cap
- $3.73B
- Volume/Avg
- 45,655 / 92,362
Key Statistics
- Price/Earnings (Normalized)
- 10.26
- Price/Sales
- 2.05
- Dividend Yield (Trailing)
- 3.88%
- Dividend Yield (Forward)
- 3.82%
- Dividend Payment Schedule
- Jan
- Total Yield
- 3.88%
Company Profile
Hypera SA is a specialty and generic drug manufacturing company. The company operates in the prescription medicines, over-the-counter (OTC) medicines, branded generics, and generics, and skincare segments within the retail pharmaceutical market. The company also has a wide sales and distribution structure. The company's product portfolio includes key brands in Gastroenterology, Pain, Sun Protection, Skin Moisture, and Cleansing within the over-the-counter (OTC) and Skincare segments, as well as new products in Cardiology, Central Nervous System, and Respiratory System within the prescription medicines segment.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Core
- Total Number of Employees
- 10,564
- Website
- https://www.hypera.com.br
Valuation
|
Metric
|
HYPMY
|
|---|---|
Price/Earnings (Normalized) | 10.26 |
Price/Book Value | 1.31 |
Price/Sales | 2.05 |
Price/Cash Flow | 11.80 |
Price/Earnings
HYPMY
Financial Strength
|
Metric
|
HYPMY
|
|---|---|
Quick Ratio | 1.20 |
Current Ratio | 1.86 |
Interest Coverage | 2.53 |
Quick Ratio
HYPMY
Profitability
|
Metric
|
HYPMY
|
|---|---|
Return on Assets (Normalized) | 6.88% |
Return on Equity (Normalized) | 13.26% |
Return on Invested Capital (Normalized) | 10.97% |
Return on Assets
HYPMY
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|%M>$$DF | LOCK|Ts#N | $70B | |||
| Teva Pharmaceutical Industries Ltd
TEVA
| LOCK|SsR!&>F | LOCK|&chwK | $48B | |||
| Haleon PLC ADR
HLN
| LOCK|B&?R&g | LOCK|@W! | $44B | |||
| Zoetis Inc Class A
ZTS
| LOCK|F!fVF@W | LOCK|%SL | $33B | |||
| Viatris Inc
VTRS
| LOCK|$fy&dB | LOCK|>! | $21B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|Fk> | LOCK|!y | $12B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|lS&ClWs | LOCK|?#& | $11B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|JVS%Xq | LOCK|W& | $7B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|!%^W%<j | LOCK|c%h@W | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|W!><cC> | LOCK|hn | $2B |
United States